Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

IL-10-producing regulatory B cells induced by IL-33 (Breg(IL-33)) effectively attenuate mucosal inflammatory responses in the gut.

Sattler S, Ling GS, Xu D, Hussaarts L, Romaine A, Zhao H, Fossati-Jimack L, Malik T, Cook HT, Botto M, Lau YL, Smits HH, Liew FY, Huang FP.

J Autoimmun. 2014 May;50:107-22. doi: 10.1016/j.jaut.2014.01.032.

2.

Role of IL-10-producing regulatory B cells in control of cerebral malaria in Plasmodium berghei infected mice.

Liu Y, Chen Y, Li Z, Han Y, Sun Y, Wang Q, Liu B, Su Z.

Eur J Immunol. 2013 Nov;43(11):2907-18. doi: 10.1002/eji.201343512.

3.

Interleukin-35 induces regulatory B cells that suppress autoimmune disease.

Wang RX, Yu CR, Dambuza IM, Mahdi RM, Dolinska MB, Sergeev YV, Wingfield PT, Kim SH, Egwuagu CE.

Nat Med. 2014 Jun;20(6):633-41. doi: 10.1038/nm.3554. Erratum in: Nat Med. 2014 Jun;20(6). doi: 10.1038/nm.3554.

4.

CD43-, but not CD43+, IL-10-producing CD1dhiCD5+ B cells suppress type 1 immune responses during Chlamydia muridarum genital tract infection.

Moore-Connors JM, Kim HS, Marshall JS, Stadnyk AW, Halperin SA, Wang J.

Mucosal Immunol. 2015 Jan;8(1):94-106. doi: 10.1038/mi.2014.45.

PMID:
24938746
5.

Autocrine stimulation of IL-10 is critical to the enrichment of IL-10-producing CD40(hi)CD5(+) regulatory B cells in vitro and in vivo.

Kim HS, Lee JH, Han HD, Kim AR, Nam ST, Kim HW, Park YH, Lee D, Lee MB, Park YM, Kim HS, Kim YM, You JC, Choi WS.

BMB Rep. 2015 Jan;48(1):54-9.

6.

Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.

Cai Z, Wong CK, Dong J, Chu M, Jiao D, Kam NW, Lam CW, Tam LS.

Clin Exp Immunol. 2015 Aug;181(2):253-66. doi: 10.1111/cei.12639.

7.

An IL-27/Lag3 axis enhances Foxp3+ regulatory T cell-suppressive function and therapeutic efficacy.

Do JS, Visperas A, Sanogo YO, Bechtel JJ, Dvorina N, Kim S, Jang E, Stohlman SA, Shen B, Fairchild RL, Baldwin Iii WM, Vignali DA, Min B.

Mucosal Immunol. 2016 Jan;9(1):137-45. doi: 10.1038/mi.2015.45.

8.

Role of regulatory B cells in chronic intestinal inflammation: association with pathogenesis of Crohn's disease.

Oka A, Ishihara S, Mishima Y, Tada Y, Kusunoki R, Fukuba N, Yuki T, Kawashima K, Matsumoto S, Kinoshita Y.

Inflamm Bowel Dis. 2014 Feb;20(2):315-28. doi: 10.1097/01.MIB.0000437983.14544.d5.

PMID:
24390063
9.

Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells.

Lindner S, Dahlke K, Sontheimer K, Hagn M, Kaltenmeier C, Barth TF, Beyer T, Reister F, Fabricius D, Lotfi R, Lunov O, Nienhaus GU, Simmet T, Kreienberg R, Möller P, Schrezenmeier H, Jahrsdörfer B.

Cancer Res. 2013 Apr 15;73(8):2468-79. doi: 10.1158/0008-5472.CAN-12-3450.

10.

B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.

Liu Z, Geboes K, Hellings P, Maerten P, Heremans H, Vandenberghe P, Boon L, van Kooten P, Rutgeerts P, Ceuppens JL.

J Immunol. 2001 Aug 1;167(3):1830-8.

11.

Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.

Kessel A, Haj T, Peri R, Snir A, Melamed D, Sabo E, Toubi E.

Autoimmun Rev. 2012 Jul;11(9):670-7. doi: 10.1016/j.autrev.2011.11.018.

PMID:
22155204
12.

Novel therapeutic compound tuftsin-phosphorylcholine attenuates collagen-induced arthritis.

Bashi T, Shovman O, Fridkin M, Volkov A, Barshack I, Blank M, Shoenfeld Y.

Clin Exp Immunol. 2016 Apr;184(1):19-28. doi: 10.1111/cei.12745.

PMID:
26618631
13.

B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells.

Jin G, Hamaguchi Y, Matsushita T, Hasegawa M, Le Huu D, Ishiura N, Naka K, Hirao A, Takehara K, Fujimoto M.

J Allergy Clin Immunol. 2013 Jun;131(6):1674-82. doi: 10.1016/j.jaci.2013.01.044.

PMID:
23534976
14.

Regulatory B cells: origin, phenotype, and function.

Rosser EC, Mauri C.

Immunity. 2015 Apr 21;42(4):607-12. doi: 10.1016/j.immuni.2015.04.005. Review.

15.

A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production.

Kaku H, Cheng KF, Al-Abed Y, Rothstein TL.

J Immunol. 2014 Dec 15;193(12):5904-13. doi: 10.4049/jimmunol.1400336.

16.

Role of IL-10-Producing Regulatory B Cells in Chronic Hepatitis B Virus Infection.

Gong Y, Zhao C, Zhao P, Wang M, Zhou G, Han F, Cui Y, Qian J, Zhang H, Xiong H, Sheng J, Jiang T.

Dig Dis Sci. 2015 May;60(5):1308-14. doi: 10.1007/s10620-014-3358-1.

PMID:
25260658
17.

Interleukin-10 From Marginal Zone Precursor B-Cell Subset Is Required for Costimulatory Blockade-Induced Transplantation Tolerance.

Lal G, Nakayama Y, Sethi A, Singh AK, Burrell BE, Kulkarni N, Brinkman CC, Iwami D, Zhang T, Bromberg JS.

Transplantation. 2015 Sep;99(9):1817-28. doi: 10.1097/TP.0000000000000718.

18.

A regulatory CD9(+) B-cell subset inhibits HDM-induced allergic airway inflammation.

Braza F, Chesne J, Durand M, Dirou S, Brosseau C, Mahay G, Cheminant MA, Magnan A, Brouard S.

Allergy. 2015 Nov;70(11):1421-31. doi: 10.1111/all.12697.

PMID:
26194936
19.

Changes in regulatory B cells and their relationship with rheumatoid arthritis disease activity.

Cui D, Zhang L, Chen J, Zhu M, Hou L, Chen B, Shen B.

Clin Exp Med. 2015 Aug;15(3):285-92. doi: 10.1007/s10238-014-0310-9.

PMID:
25245953
20.

Induction of IL-10-producing CD1dhighCD5+ regulatory B cells following Babesia microti-infection.

Jeong YI, Hong SH, Cho SH, Lee WJ, Lee SE.

PLoS One. 2012;7(10):e46553. doi: 10.1371/journal.pone.0046553.

Items per page

Supplemental Content

Support Center